title: Puberty menorrhagia requiring inpatient admission.
abstract: BACKGROUND
  Puberty menorrhagia is a significant health problem in adolescent age group and severe cases may require admission and blood transfusion. Aim of this study was to evaluate the causes, associated complications and management of puberty menorrhagia.
  
  
  METHODS
  Hospital records of all patients of puberty menorrhagia requiring admission were analyzed for etiology, duration since menarche, duration of bleeding, investigation profile and management.
  
  
  RESULTS
  There were 18 patients of puberty menorrhagia requiring hospital admission. Etiology was anovulatory bleeding in 11 patients, bleeding disorders in five which included idiopathic thrombocytopenia purpura in three and one each with Von-Willebrand disease and leukemia. Two patients had hypothyroidism as the cause. Fourteen patients presented with severe anaemia and required blood transfusion. All except one responded to oral hormonal therapy.
  
  
  CONCLUSIONS
  Puberty menorrhagia can be associated with severe complications and requiring blood transfusion. Although most common cause is anovulation but bleeding disorder, other medical condition and other organic causes must be ruled out in any patient of Puberty menorrhagia.
authors.affiliation: Department of Obstetrics & Gynaecology, Government Medical College and Hospital, Chandigarh, India.
authors.forename: A H
authors.initials: AH
authors.lastname: Khosla
authors.forename: L
authors.initials: L
authors.lastname: Devi
authors.forename: P
authors.initials: P
authors.lastname: Goel
authors.forename: P K
authors.initials: PK
authors.lastname: Saha
mesh_terms: D000293:Adolescent; D000740:Anemia / Q000209:etiology; D000858:Anovulation / Q000150:complications; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D002648:Child; D003276:Contraceptives, Oral / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000150:complications; D007938:Leukemia / Q000150:complications; D008572:Menarche; D008595:Menorrhagia / Q000150:complications* / Q000188:drug therapy* / Q000209:etiology; D011372:Progestins / Q000627:therapeutic use*; D011627:Puberty; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications; D012189:Retrospective Studies; D014148:Tranexamic Acid / Q000627:therapeutic use*; D014842:von Willebrand Diseases / Q000150:complications
chemical_list: D000933:Antifibrinolytic Agents; D003276:Contraceptives, Oral; D011372:Progestins; D014148:Tranexamic Acid